共 63 条
[1]
Kessler RC(2013)The epidemiology of depression across cultures Annu Rev Public Health 34 119-138
[2]
Bromet EJ(2013)Disability mediates the impact of common conditions on perceived health PLoS One 8 e65858-49
[3]
Alonso J(2012)Recovery from depression Psychiatr Clin North Am 35 37-40
[4]
Vilagut G(2006)Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry 163 28-354
[5]
Adroher ND(2000)Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351-236
[6]
Stotland NL(2007)Intravenous ketamine therapy in a patient with a treatment-resistant major depression Swiss Med Wkly 137 234-864
[7]
Trivedi MH(2006)A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 856-438
[8]
Rush AJ(2010)Replication of scopolamine’s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial Biol Psychiatry 67 432-1129
[9]
Wisniewski SR(2006)Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial Arch Gen Psychiatry 63 1121-2488
[10]
Berman RM(2010)Scopolamine produces larger antidepressant and antianxiety effects in women than in men Neuropsychopharmacology 35 2479-67